Markets.com Logo

ADXS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0532$
  • Previous Close
    0.0532$
  • 52 Week Change
    0.76$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.02$ - 0.777$
  • Dividend Per Share
    --
  • Market cap
    2 257 K$
  • EPS
    0
  • Beta
    --
  • Volume
    --

About

ADXS.US was the stock ticker symbol for Advaxis, Inc., a biotechnology company focused on developing cancer immunotherapies. Advaxis was based in Princeton, New Jersey, and their primary technology platform was based on Listeria monocytogenes (Lm)-based antigen delivery. The company aimed to harness the power of the body's immune system to target and destroy cancer cells. However, Advaxis struggled financially and operationally. Trading of ADXS.US was ultimately suspended, and the company entered bankruptcy. The stock is no longer actively traded on major exchanges.

Gold Market Analysis: Fed Policy Impact on Prices and Driving Factors

Emma Rose|--

US Stock Market Correction: Banks Warn of Lingering Risks Amidst Shifting Momentum

Ava Grace|--

Bond Market Re-evaluation Amid Geopolitical Shifts and Inflationary Pressures

Sophia Claire|--

SpaceX IPO Momentum Builds: MSCI Inclusion Expected to Drive Significant Inflows

Noah Lee|--

Intel Foundry Poised for Major Gains with Potential Google and Nvidia Partnerships

Ava Grace|--

Federal Reserve's Tightrope Walk: Inflation, Labor Market, and Policy Crossroads

Noah Lee|--

Global Financial Tightening: A Looming Risk on the Horizon

Noah Lee|--

Factors

Clinical Trial Results: Positive data from Advaxis' clinical trials often leads to increased investor confidence and higher stock prices. Conversely, negative or inconclusive results can cause the price to fall.

Regulatory Approvals: FDA approvals for Advaxis' immunotherapy drugs are major catalysts that typically drive significant stock price increases. Rejections or delays can negatively impact the stock.

Partnerships and Collaborations: Strategic partnerships with larger pharmaceutical companies or research institutions can boost investor sentiment and increase the stock price due to validation and potential funding.

Financial Performance: Advaxis' cash position, burn rate, and ability to secure funding influence investor confidence. Concerns about financial stability can depress the stock price.

Market Sentiment: Overall market conditions and investor appetite for risk, particularly in the biotech sector, can affect ADXS.US. Positive market sentiment tends to lift the stock.

Competition: The competitive landscape in the immunotherapy space impacts investor perception of Advaxis' potential. Strong competition can pressure the stock price.

News and Media Coverage: News articles, analyst ratings, and social media discussions can influence investor behavior and affect the stock price.

People Also Watch

Latest news

Economic Volatility, Inflation Fears, and AI-Driven Stock Market Dynamics

Liam James|--

India's Gold Smuggling Surges Post Tariff Hike, Shadow Market Dominates

Liam James|--

Pakistan: US-Iran Peace Deal Unlikely Soon Amid Israeli Ceasefire Violations

Ava Grace|--

Latest Education Articles

What Are Government Bonds? A Beginner’s Guide to How They Work

What Are Government Bonds? A Beginner’s Guide to How They Work

Julian Parker|--
Money Management Strategies in Trading

Money Management Strategies in Trading

Julian Parker|--
What Is OTC Trading? How Over-the-Counter Markets Work

What Is OTC Trading? How Over-the-Counter Markets Work

Julian Parker|--
Recommended Topics